Investing in Liquid Biopsies

One of the more interesting companies in this space is Epic Sciences who recently announced the completion of a Series D funding round.  What is very interesting about Epic’s approach is their “no cell left behind” approach.  By maintaining all cells on a slide, there is an opportunity to better classify and categorize what is going on.